01—Abstract
Summary
Summary of the 8-K filed October 30, 2024. Cited figures are marked; the original filing is the authoritative source.
On October 30, 2024, MicroStrategy Incorporated entered into a Sales Agreement with ten sales agents, including TD Securities (USA) LLC, Barclays Capital Inc., and Cantor Fitzgerald & Co., under which it may issue and sell shares of its class A common stock, $0.001a par value, having an aggregate offering price of up to $21.0 billion.
The shares may be sold from time to time through the agents in an "at the market offering" as defined under Rule 415(a)(4) of the Securities Act of 1933. MicroStrategy is under no obligation to sell any shares, will sell through only one agent on any given day, and may suspend or terminate the offering upon notice. MicroStrategy agreed to pay the agents commissions of up to 2.0%b of the aggregate gross proceeds from each sale and to provide customary indemnification and contribution rights.
The shares are being offered under the company's automatic shelf registration statement (File No. 333-281175), which became effective on August 1, 2024, and a prospectus supplement filed on the same day. Counsel Wilmer Cutler Pickering Hale and Dorr LLP issued a legal opinion on the shares, filed as Exhibit 5.1.
For investors, the filing establishes a capacity for up to $21.0 billionc of new equity issuance through the agents, but it does not state how much of that capacity has been used or the company's intended use of proceeds. The filing itself is an announcement of the program's establishment rather than of any completed sale.
02—Key points
Key Highlights
- Entered a Sales Agreement dated October 30, 2024 with ten sales agents, including TD Securities, Barclays, Benchmark, BTIG, Canaccord Genuity, Cantor Fitzgerald, Maxim, Mizuho, and SG Americas.
- Authorized an at-the-market offering of class A common stock with an aggregate offering price of up to $21.0 billion.
- Sales are made at MicroStrategy's discretion; it has no obligation to sell any shares and will sell through only one agent on any single day.
- Agents' commissions are up to 2.0% of aggregate gross proceeds from each sale.
- Offering is made under an automatic shelf registration statement (File No. 333-281175) effective August 1, 2024, with a prospectus supplement filed October 30, 2024.
- Offering may be suspended or terminated by MicroStrategy or the agents upon notice, and the agents act on a commercially reasonable efforts basis.
03—Questions
Frequently Asked Questions
How large is the at-the-market equity program?
The Sales Agreement covers the sale of Common Stock having an aggregate offering price of up to $21.0 billion.
Is MicroStrategy required to sell shares under this program?
No. The filing states that MicroStrategy has no obligation to sell any of the Shares and will determine the amounts and timing of sales from time to time.
What fees will MicroStrategy pay to the sales agents?
MicroStrategy agreed to pay commissions of up to 2.0% of the aggregate gross proceeds it receives from each sale of Shares under the Sales Agreement.
How can the offering be stopped or changed?
MicroStrategy or the Agents may suspend or terminate the Offering upon notice to the other parties and subject to other conditions. Each Agent acts as sales agent on a commercially reasonable efforts basis.
Under what registration are the shares being sold?
The shares are registered under an automatic shelf registration statement (File No. 333-281175) that became effective on August 1, 2024, and are offered only by means of a prospectus supplement filed on October 30, 2024.
04—Continue